KERI HYDE: Open Payments
NPI 1982084877 · CHELSEA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,679 in 125 payments from 24 companies in 2025. Trend: 2023 $1,936 · 2024 $1,995 · 2025 $2,679
Food & beverage: $2,679
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $463 |
| Novo Nordisk Inc | 17 | $295 |
| Axsome Therapeutics, Inc. | 16 | $277 |
| PFIZER INC. | 15 | $262 |
| AstraZeneca Pharmaceuticals LP | 6 | $210 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $176 |
| Otsuka America Pharmaceutical, Inc. | 1 | $121 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $115 |
| Dexcom, Inc. | 4 | $115 |
| INTUITIVE SURGICAL, INC. | 1 | $93 |
Products named: NURTEC ODT, Symbravo, Kerendia, Wegovy, VRAYLAR, UBRELVY, BREZTRI, QULIPTA.
Industry payments across AL — which companies pay providers there.
